Centurion İlaç is a prominent player in the Biotechnology and Pharmaceutical industries, stemming from its deep roots since being founded in 1949. This Turkish company is noted for its extensive reach both domestically and internationally, with operations across over 15 countries. Its strong emphasis on advancing treatment options, specifically for Orphan disease, Plasma products, Hospital injectable, and Vaccines, establishes it as a key contributor to modern healthcare.
The establishment of its R&D Department in 2011 marks a pivotal shift towards the development and manufacturing of specialist-oriented products locally, reflecting a commitment to innovation in health solutions. Centurion’s core philosophy revolves around ensuring every patient has access to cutting-edge treatments, guided by their slogan: "Her hasta modern tedavi şansını ve yüksek yaşam kalitesini hak eder…” Despite its longstanding presence, the company has not disclosed recent investment activities.